PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1

Rachel Ziliotto1, Marek R Gruca1, Shreya Podder1

  • 1Department of Microbiology and Immunology and the Centre for Human Immunology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Experimental Hematology
|December 10, 2013
PubMed

Insights

Reduced PU.1 (Sfpi1) levels drive acute myeloid leukemia (AML) by promoting myeloid cell proliferation and blocking differentiation. This study reveals PU.1 controls cell cycle exit via E2F1 downregulation.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acute myeloid leukemia (AML) is a cancer of myeloid lineage cells, marked by uncontrolled proliferation and impaired differentiation.
  • Mutations in transcription factors, including PU.1 (Sfpi1), are frequently implicated in AML development.
  • Reduced PU.1 expression is a known factor in human AML and can induce AML in murine models.

Purpose of the Study:

  • To investigate if diminished PU.1 expression leads to cell cycle deregulation in myeloid cells.
  • To elucidate the molecular mechanisms by which PU.1 influences myeloid cell proliferation and differentiation.

Main Methods:

  • Analysis of myeloid cells with reduced PU.1 levels (Sfpi1(BN/BN)) in vitro and in vivo.
  • Assessment of cell proliferation, differentiation, and E2F1 expression.
  • Transplantation studies in recipient mice to evaluate AML induction.

Main Results:

  • Myeloid cells with reduced PU.1 proliferated uncontrollably in culture and expanded in vivo.
  • Transplantation of these cells induced AML in mice.
  • Reduced PU.1 expression correlated with increased E2F1 (a cell cycle regulator) transcript and protein levels.
  • Restoring PU.1 expression halted proliferation, promoted differentiation, and decreased E2F1 levels.

Conclusions:

  • PU.1 is essential for controlling cell cycle exit in the myeloid lineage.
  • PU.1 exerts its function by downregulating the expression of E2F1.
  • Targeting the PU.1/E2F1 pathway may offer therapeutic strategies for AML.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K